nach oben

Erschienen in:

20.08.2016 | Original Article

Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic T_reg in chronically HCV-infected patients

verfasst von: Minesh Mehta, Helal F. Hetta, Enass A. Abdel-hameed, Susan D. Rouster, MdMonir Hossain, Mohamed A. Mekky, Nasr K. Khalil, Wegdan A. Mohamed, Mohamed A. El-Feky, Shabaan H. Ahmed, Enas A. Daef, Mohamed A. El-Mokhtar, Sayed F. Abdelwahab, Ahmed Medhat, Kenneth E. Sherman, Mohamed Tarek M. Shata

Erschienen in: Archives of Virology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

The IL28B gene is associated with spontaneous or treatment-induced HCV viral clearance. However, the mechanism by which the IL28B single nucleotide polymorphism (SNP) affects the extra-hepatic HCV immune responses and its relationship to HCV pathogenesis have not been thoroughly investigated. To examine the mechanism by which IL28B affects HCV clearance. Forty Egyptian patients with chronic HCV infection receiving an Interferon/ribavirin treatment regimen were enrolled into this study. There were two groups: non-responders (NR; n = 20) and sustained virologic responders (SVR; n = 20). The initial plasma HCV viral loads prior to treatment and IL28B genotypes were determined by quantitative RT-PCR and sequencing, respectively. Liver biopsies were examined to determine the inflammatory score and the stage of fibrosis. Colonic regulatory T cell (T_reg) frequency was estimated by immunohistochemistry. No significant association between IL28B genotypes and response to therapy was identified, despite an odds ratio of 3.4 to have the TT genotype in NR compared to SVR (95 % confidence interval 0.3-35.3, p = 0.3). Patients with the TT-IL28Brs12979860 genotype (unfavorable genotype) have significantly higher frequencies of colonic T_reg compared to the CT (p = 0.04) and CC (p = 0.03) genotypes. The frequency of colonic T_reg cells in HCV-infected patients had a strong association with the IL-28B genotype and may have a significant impact on HCV clearance.

Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41–52CrossRefPubMed

Gouda I, Nada O, Ezzat S, Eldaly M, Loffredo C, Taylor C et al (2010) Immunohistochemical detection of hepatitis C virus (genotype 4) in B-cell NHL in an Egyptian population: correlation with serum HCV-RNA. Appl Immunohistochem Mol Morphol 18:29–34CrossRefPubMedPubMedCentral

Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS et al (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887–891CrossRefPubMed

Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ et al (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399–401CrossRefPubMed

McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K et al (2010) Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 138:2307–2314CrossRefPubMedPubMedCentral

Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T et al (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138:1338–1345; 1345 e1331–1337

Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML et al (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41:1100–1104CrossRefPubMed

Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N et al (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105–1109CrossRefPubMed

Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O’Huigin C et al (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798–801CrossRefPubMedPubMedCentral

10.

Youssef SS, Abbas EA, Abd el Aal AM, el Zanaty T, Seif SM (2014) Association of IL28B polymorphism with fibrosis, liver inflammation, gender respective natural history of hepatitis C virus in egyptian patients with genotype 4. J Interferon Cytokine Res 34:22–27CrossRefPubMed

11.

Youssef SS, Abbas EA, Abd El Aal AM, Omran MH, Barakat A, Seif SM (2014) IL28B rs 12979860 Predicts response to treatment in Egyptian hepatitis C virus genotype 4 patients and alpha fetoprotein increases its predictive strength. J Interferon Cytokine Res

12.

Shaker OG, Sadik NA (2012) Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy. J Gastroenterol Hepatol 27:1842–1849CrossRefPubMed

13.

El-Kamary SS, Hashem M, Saleh DA, Abdelwahab SF, Sobhy M, Shebl FM et al (2013) Hepatitis C virus-specific cell-mediated immune responses in children born to mothers infected with hepatitis C virus. J Pediatr 162:148–154CrossRefPubMedPubMedCentral

14.

Fitzmaurice K, Hurst J, Dring M, Rauch A, McLaren PJ, Gunthard HF et al (2015) Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection. Gut 64:813–819CrossRefPubMed

15.

Umemura T, Ota M, Katsuyama Y, Wada S, Mori H, Maruyama A et al (2014) KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C. Hum Immunol 75:822–826CrossRefPubMed

16.

Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE et al (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63–68CrossRefPubMed

17.

Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK et al (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69–77CrossRefPubMed

18.

Hamming OJ, Terczynska-Dyla E, Vieyres G, Dijkman R, Jorgensen SE, Akhtar H et al (2013) Interferon lambda 4 signals via the IFNlambda receptor to regulate antiviral activity against HCV and coronaviruses. EMBO J 32:3055–3065CrossRefPubMedPubMedCentral

19.

Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H et al (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164–171CrossRefPubMedPubMedCentral

20.

O’Brien TR, Prokunina-Olsson L, Donnelly RP (2014) IFN-lambda4: the paradoxical new member of the interferon lambda family. J Interferon Cytokine Res 34:829–838CrossRefPubMedPubMedCentral

21.

Mennechet FJ, Uze G (2006) Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107:4417–4423CrossRefPubMed

22.

Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S et al (2012) Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS One 7:e44915CrossRefPubMedPubMedCentral

23.

Hartling HJ, Gaardbo JC, Ronit A, Knudsen LS, Ullum H, Vainer B et al (2012) CD4(+) and CD8(+) regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection. Scand J Immunol 76:294–305CrossRefPubMed

24.

Bolacchi F, Sinistro A, Ciaprini C, Demin F, Capozzi M, Carducci FC, Drapeau CMJ, Rocchi G, Bergamini A (2006) Increased hepatitis C virus (HCV)-specific CD4+ CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 144:88–196CrossRef

25.

Sturm N, Thelu MA, Camous X, Dimitrov G, Ramzan M, Dufeu-Duchesne T et al (2010) Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis. J Hepatol 53:25–35CrossRefPubMed

26.

Keynan Y, Card CM, McLaren PJ, Dawood MR, Kasper K, Fowke KR (2008) The role of regulatory T cells in chronic and acute viral infections. Clin Infect Dis 46:1046–1052CrossRefPubMed

27.

Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775–787CrossRefPubMed

28.

Magg T, Mannert J, Ellwart JW, Schmid I, Albert MH (2012) Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells. Eur J Immunol 42:1627–1638CrossRefPubMed

29.

Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, Klenerman P et al (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79:7852–7859CrossRefPubMedPubMedCentral

30.

Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C et al (2005) T cells with a CD4+ CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79:7860–7867CrossRefPubMedPubMedCentral

31.

Itose I, Kanto T, Kakita N, Takebe S, Inoue M, Higashitani K et al (2009) Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis. J Viral Hepat 16:844–852CrossRefPubMed

32.

Amoroso A, D’Amico F, Consolo M, Skarmoutsou E, Neri S, Dianzani U et al (2012) Evaluation of circulating CD4+ CD25+ and liver-infiltrating Foxp3+ cells in HCV-associated liver disease. Int J Mol Med 29:983–988PubMed

33.

Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM (2003) Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38:1437–1448PubMed

34.

Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, Chapman RW et al (2007) Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 47:316–324CrossRefPubMed

35.

Hetta HF, Mekky MA, Khalil NK, Mohamed WA, El-Feky MA, Ahmed SH et al (2015) Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology. J Gastroenterol Hepatol 30:1543–1551CrossRefPubMedPubMedCentral

36.

Hetta HF, Mekky MA, Khalil NK, Mohamed WA, El-Feky MA, Ahmed SH et al (2016) Extra-hepatic infection of HCV in the colon tissue and its relationship with HCV pathogenesis. J Med Microbiol

37.

Gualdi R, Bossard P, Zheng M, Hamada Y, Coleman JR, Zaret KS (1996) Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev 10:1670–1682CrossRefPubMed

38.

El-sherif WTSS, Afifi NA, EL-Amin HA (2012) Occult hepatitis B infection among Egyptian chronic hepatitis C patients and its relation with liver enzymes and hepatitis B markers. Life Sci 9:467–474

39.

Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293CrossRefPubMed

40.

Zekri AR, Salama H, Medhat E, Bahnassy AA, Morsy HM, Lotfy MM et al (2014) IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV. Asian Pac J Cancer Prev 15:7213–7218CrossRefPubMed

41.

Murakawa M, Asahina Y, Nakagawa M, Sakamoto N, Nitta S, Kusano-Kitazume A et al (2015) Impaired induction of interleukin 28B and expression of interferon lambda 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C. J Gastroenterol Hepatol 30:1075–1084CrossRefPubMed

42.

Marabita F, Aghemo A, De Nicola S, Rumi MG, Cheroni C, Scavelli R et al (2011) Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection. Hepatology 54:1127–1134CrossRefPubMed

43.

Iijima S, Matsuura K, Watanabe T, Onomoto K, Fujita T, Ito K et al (2015) Influence of genes suppressing interferon effects in peripheral blood mononuclear cells during triple antiviral therapy for chronic hepatitis C. PLoS One 10:e0118000CrossRefPubMedPubMedCentral

44.

Barbi J, Pardoll D, Pan F (2014) Treg functional stability and its responsiveness to the microenvironment. Immunol Rev 259:115–139CrossRefPubMedPubMedCentral

45.

Zhan Y, Davey GM, Graham KL, Kiu H, Dudek NL, Kay T et al (2009) SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus. Immunol Cell Biol 87:473–480CrossRefPubMed

46.

Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T et al (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142:914–929CrossRefPubMedPubMedCentral

47.

Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW (1996) Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759–765CrossRefPubMed

48.

Quiroga JA, Martin J, Navas S, Carreno V (1998) Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage. J Infect Dis 178:247–251CrossRefPubMed

49.

Abrignani S (1997) Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol 19:47–55CrossRefPubMed

50.

Rehermann B (2000) Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 20:127–141CrossRefPubMed

51.

Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C et al (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40:1062–1071CrossRefPubMed

52.

D’Ambrosio R, Aghemo A, De Francesco R, Rumi MG, Galmozzi E, De Nicola S et al (2014) The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent. Int J Mol Sci 15:7213–7224CrossRefPubMedPubMedCentral

53.

Falleti E, Bitetto D, Fabris C, Cussigh A, Fornasiere E, Cmet S et al (2011) Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. J Clin Immunol 31:891–899CrossRefPubMed

Titel: Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients
verfasst von: Minesh Mehta
Helal F. Hetta
Enass A. Abdel-hameed
Susan D. Rouster
MdMonir Hossain
Mohamed A. Mekky
Nasr K. Khalil
Wegdan A. Mohamed
Mohamed A. El-Feky
Shabaan H. Ahmed
Enas A. Daef
Mohamed A. El-Mokhtar
Sayed F. Abdelwahab
Ahmed Medhat
Kenneth E. Sherman
Mohamed Tarek M. Shata
Publikationsdatum: 20.08.2016
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 11/2016
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-016-3015-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic T_reg in chronically HCV-infected patients

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2016

Complete genome sequence of a novel potyvirus, callistephus mottle virus, identified in Callistephus chinensis

A new densovirus in cerebrospinal fluid from a case of anti-NMDA-receptor encephalitis

Exploration of the BF2*15 major histocompatibility complex class I binding motif and identification of cytotoxic T lymphocyte epitopes from the H5N1 influenza virus nucleoprotein in chickens

Genomic and proteomic characterization of SE-I, a temperate bacteriophage infecting Erysipelothrix rhusiopathiae

Bovine leukemia virus becomes established in dairy herds before the first lactation

IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin